We are live on ! Find out more
MAM

Monaco Asset Management Portfolio holdings

AUM $542M
1-Year Est. Return 54.4%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+54.4%
3 Year Est. Return
+96.99%
5 Year Est. Return
10 Year Est. Return
AUM
$334M
AUM Growth
-$5.65M
Cap. Flow
-$30.5M
Cap. Flow %
-9.12%
Top 10 Hldgs %
62.07%
Holding
89
New
11
Increased
12
Reduced
29
Closed
33

Top Buys

Rank Stock Value
1
GDX icon
VanEck Gold Miners ETF
GDX
+$16.3M
2
VTRS icon
Viatris
VTRS
+$5.29M
3
ZM icon
Zoom
ZM
+$5.07M
4
BIDU icon
Baidu
BIDU
+$3.01M
5
PARA
Paramount Global Class B
PARA
+$1.64M

Top Sells

Rank Stock Value
1
FATE icon
Fate Therapeutics
FATE
+$11.6M
2
AEM icon
Agnico Eagle Mines
AEM
+$8.05M
3
PFE icon
Pfizer
PFE
+$5.76M
4
PYPL icon
PayPal
PYPL
+$4.54M
5
B
Barrick Mining
B
+$4.48M

Sector Composition

Rank Sector Weight
1 Healthcare 22.24%
2 Materials 18.8%
3 Technology 6.47%
4 Communication Services 3.47%
5 Consumer Discretionary 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPT
76
CALL
Medical Properties Trust
MPT
$2.77B
-200,000
Closed -$982K
NVCR icon
77
NovoCure
NVCR
$1.73B
-45,336
Closed -$677K
OMF icon
78
CALL
OneMain Financial
OMF
$7.2B
-50,000
Closed -$2.46M
PANW icon
79
PUT
Palo Alto Networks
PANW
$270B
-50,000
Closed -$7.37M
PFE icon
80
Pfizer
PFE
$143B
-200,000
Closed -$5.76M
PRGO icon
81
Perrigo
PRGO
$1.4B
-20,000
Closed -$644K
RACE icon
82
PUT
Ferrari
RACE
$69.2B
-100,000
Closed -$33.8M
RNG icon
83
RingCentral
RNG
$4.66B
-40,000
Closed -$1.36M
TSHA icon
84
Taysha Gene Therapies
TSHA
$1.68B
-295,000
Closed -$522K
VNDA icon
85
Vanda Pharmaceuticals
VNDA
$307M
-85,000
Closed -$359K
VTRS icon
86
CALL
Viatris
VTRS
$20.4B
-133,600
Closed -$1.45M
BCOV
87
DELISTED
Brightcove, Inc.
BCOV
-55,000
Closed -$142K
TSP
88
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
-3,053,587
Closed -$2.68M
EAR
89
DELISTED
Eargo, Inc. Common Stock
EAR
-50,000
Closed -$130K

Similar funds

Monaco Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Monaco Asset Management held 89 positions worth $334M, down 1.7% from $340M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Monaco Asset Management withdrew a net $30.5M in Q1 2024, closing 33 positions and reducing 29 holdings. Its most notable exit was Pfizer, an estimated $5.76M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Materials and Technology.

Against the trend, Monaco Asset Management opened a new position in VanEck Gold Miners ETF worth $18.2M.

  • Monaco Asset Management's largest Q1 2024 buy was VanEck Gold Miners ETF: 574,500 shares worth $18.2M.
  • Monaco Asset Management added most to Viatris in Q1 2024, an estimated $5.29M increase.
  • Monaco Asset Management's biggest Q1 2024 reduction was Fate Therapeutics, cutting an estimated $11.6M.
  • Monaco Asset Management fully exited Pfizer in Q1 2024, selling an estimated $5.76M.
  • Monaco Asset Management's ten largest holdings make up 62% of its $334M portfolio in Q1 2024.
  • Monaco Asset Management opened 11 new positions and closed 33 in Q1 2024.
  • Monaco Asset Management's portfolio value fell 1.7% quarter-over-quarter to $334M.

Based on Monaco Asset Management's 13F filing for Q1 2024, filed 9 May 2024.